76 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
4
Fluorinated Chaperone-ß-Cyclodextrin Formulations forß-Glucocerebrosidase Activity Enhancement in Neuronopathic Gaucher Disease.
University of Sevilla
10
Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp(2)-iminosugar conjugates against glycosidases: A structure-activity relationship study in Gaucher fibroblasts.
University of Seville
39
Design and Synthesis of Potent Quinazolines as Selectiveß-Glucocerebrosidase Modulators.
Northwestern University Feinberg School of Medicine
6
Conformationally-locked N-glycosides: exploiting long-range non-glycone interactions in the design of pharmacological chaperones for Gaucher disease.
Universitat Rovira I Virgili
77
Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors.
Leiden University
7
Concise synthesis of C-1-cyano-iminosugars via a new Staudinger/aza Wittig/Strecker multicomponent reaction strategy.
Technical University Graz
4
Docking and SAR studies of calystegines: binding orientation and influence on pharmacological chaperone effects for Gaucher's disease.
University of Toyama
8
Rapid modifications of N-substitution in iminosugars: development of newß-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
Genomics Research Center
6
Skeletal rearrangement of seven-membered iminosugars: synthesis of (-)-adenophorine, (-)-1-epi-adenophorine and derivatives and evaluation as glycosidase inhibitors.
University of Poitiers
3
(3R,4S,5R,6R,7S)-3,4,5,7-Tetrahydroxyconidine, an azetidine analogue of 6,7-diepicastanospermine and a conformationally constrained d-deoxyaltronojirimycin, from l-arabinose.
University of Oxford
21
Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
Peking University
27
a-1-C-butyl-1,4-dideoxy-1,4-imino-l-arabinitol as a second-generation iminosugar-based orala-glucosidase inhibitor for improving postprandial hyperglycemia.
University of Toyama
6
Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase.
National Center For Advancing Translation Sciences
2
Conformationally-locked N-glycosides with selectiveß-glucosidase inhibitory activity: identification of a new non-iminosugar-type pharmacological chaperone for Gaucher disease.
Universitat Rovira I Virgili
10
Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.
Institut De Qu£Mica Avan£Ada De Catalunya (Iqac-Csic)
19
Rapid assembly of a library of lipophilic iminosugars via the thiol-ene reaction yields promising pharmacological chaperones for the treatment of Gaucher disease.
University of British Columbia
6
The myo-1,2-Diaminocyclitol Scaffold Defines Potent Glucocerebrosidase Activators and Promising Pharmacological Chaperones for Gaucher Disease.
TBA
16
Click chemistry approach to new N-substituted aminocyclitols as potential pharmacological chaperones for Gaucher disease.
Universitat De Barcelona
12
In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.
Hokuriku University
17
Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton.
University of Tokyo
4
Homoisofagomines: chemical-enzymatic synthesis and evaluation as alpha- and beta-glucosidase inhibitors.
Technische Universit£T Berlin
4
A new strong inhibitor of beta-mannosidase.
S.E.S.N.A.B., Pole Sciences Et Technologie, Universit�
8
Potent glycosidase inhibitors, N-phenyl cyclic isourea derivatives of 5-amino- and 5-amino-1-C-(hydroxymethyl)-cyclopentane-1,2,3,4-tetraols
TBA
9
The Interaction of Anhydroalditols with Sweet-Almond -glucosidase and Escherichia coli -galactosidase: implications for the design of potent glycosidase inhibitors
TBA
4
Towards a stable noeuromycin analog with a D-manno configuration: synthesis and glycosidase inhibition of D-manno-like tri- and tetrahydroxylated azepanes.
Umr Cnrs 7201
7
Synthesis and glycosidase inhibitory profiles of functionalised morpholines and oxazepanes.
University of Reading
13
Docking and SAR studies of D- and L-isofagomine isomers as humanß-glucocerebrosidase inhibitors.
University of Toyama
27
New glucocerebrosidase inhibitors by exploration of chemical diversity of N-substituted aminocyclitols using click chemistry and in situ screening.
Spanish National Research Council (Consejo Superior De Investigaciones Cienti£?Ficas)
4
Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher's disease.
Aarhus University
26
Identification of Potent and Selective Glucosylceramide Synthase Inhibitors from a Library of N-Alkylated Iminosugars
TBA
5
Fluorescent-tagged sp2-iminosugars with potentß-glucosidase inhibitory activity.
Universidad De Sevilla
1
Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.
Harvard Medical School
9
Synthesis of new beta-1-C-alkylated imino-L-iditols: A comparative study of their activity as beta-glucocerebrosidase inhibitors.
Orleans University
3
Nanomolar affinity, iminosugar-based chemical probes for specific labeling of lysosomal glucocerebrosidase.
Utrecht University
9
Synthesis and biological evaluation of four stereoisomers of PDMP-analogue, N-(2-decylamino-3-hydroxy-3-phenylprop-1-yl)-β-valienamine, and related compounds
TBA
5
Synthesis and biological activity of C-6 modified derivatives of the glucosidase inhibitor 1-deoxynojirimycin.
TBA
7
Glycosidase-inhibiting pyrrolidines and pyrrolizidines with a long side chain in Scilla peruviana.
Hokuriku University
2
Acetal functionalized iminosugars for targeting β-glucocerebrosidase modulation.
"Ugo Schiff" (DICUS)
40
Design and synthesis of 6-C-alkyl-DMDP type nanomolar inhibitors of β-galactosidase and β-glucosidase based on broussonetine S and related derivatives.
Beijing National Laboratory For Molecular Sciences
18
Fragment-Based Discovery of a Series of Allosteric-Binding Site Modulators of β-Glucocerebrosidase.
Astex Pharmaceuticals
28
Identification of novel glucocerebrosidase chaperones by unexpected skeletal rearrangement reaction.
Eisai
39
Identification of pyrimidinyl piperazines as non-iminosugar glucocerebrosidase (GCase) pharmacological chaperones.
Eisai
29
trans, trans-2-C-Aryl-3,4-dihydroxypyrrolidines as potent and selective β-glucosidase inhibitors: Pharmacological chaperones for Gaucher disease.
Chinese Academy of Sciences
26
Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore.
Takeda Pharmaceutical
21
Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease.
Universidad De Sevilla
5
Powerful probes for glycosidases: novel, fluorescently tagged glycosidase inhibitors.
Institut FüR Biochemie Der Technischen UniversitäT Graz
7
Novel, lipophilic derivatives of 2,5-dideoxy-2,5-imino-D-mannitol (DMDP) are powerful beta-glucosidase inhibitors.
Technische UniversitäT Graz
5
Novel compounds that reverse the disease phenotype in Type 2 Gaucher disease patient-derived cells.
Temple University
19
Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase.
Northwestern University
15
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease.
University of Napoli Federico Ii
3
Synthesis and evaluation of glucocerebrosidase inhibitory activity of anhydro deoxyinositols from (+)-epi- and (-)-vibo-quercitols.
Keio University
8
Tuning of β-glucosidase and α-galactosidase inhibition by generation and in situ screening of a library of pyrrolidine-triazole hybrid molecules.
University of Seville
2
N-Butyl-l-deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer ofα-Glucosidase Activity for the Treatment of Pompe Disease.
University of Naples Federico II
22
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
Forma Therapeutics
11
Quinazoline derivatives substituted by aniline, preparation method and use thereof
Xuanzhu Pharma
22
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer
5
Plasmodium falciparum UvrD activities are downregulated by DNA-interacting compounds and its dsRNA inhibits malaria parasite growth.
International Centre For Genetic Engineering and Biotechnology
1
N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia
Pfizer
9
Hexahydropyrrolo[3,4-b]pyrrole derivatives, preparation methods and pharmaceutical uses thereof
Shanghai Sun-Sail Pharmaceutical Science & Technology
1
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.
Smithkline Beecham Pharmaceuticals
8
Molecular cloning and pharmacological characterization of a new galanin receptor subtype.
The Schering Plough Research Institute
20
Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: synthesis, structure-activity relationship, and X-ray crystal structure analysis.
Dupont Pharmaceuticals
7
Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors.
Dupont Pharmaceuticals